Correlation Between Y MAbs and Agios Pharm
Can any of the company-specific risk be diversified away by investing in both Y MAbs and Agios Pharm at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Y MAbs and Agios Pharm into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Y mAbs Therapeutics and Agios Pharm, you can compare the effects of market volatilities on Y MAbs and Agios Pharm and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Y MAbs with a short position of Agios Pharm. Check out your portfolio center. Please also check ongoing floating volatility patterns of Y MAbs and Agios Pharm.
Diversification Opportunities for Y MAbs and Agios Pharm
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between YMAB and Agios is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Y mAbs Therapeutics and Agios Pharm in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agios Pharm and Y MAbs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Y mAbs Therapeutics are associated (or correlated) with Agios Pharm. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agios Pharm has no effect on the direction of Y MAbs i.e., Y MAbs and Agios Pharm go up and down completely randomly.
Pair Corralation between Y MAbs and Agios Pharm
Given the investment horizon of 90 days Y mAbs Therapeutics is expected to under-perform the Agios Pharm. In addition to that, Y MAbs is 1.51 times more volatile than Agios Pharm. It trades about -0.14 of its total potential returns per unit of risk. Agios Pharm is currently generating about -0.19 per unit of volatility. If you would invest 3,522 in Agios Pharm on December 23, 2024 and sell it today you would lose (392.00) from holding Agios Pharm or give up 11.13% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Y mAbs Therapeutics vs. Agios Pharm
Performance |
| Timeline |
| Y mAbs Therapeutics |
| Agios Pharm |
Y MAbs and Agios Pharm Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Y MAbs and Agios Pharm
The main advantage of trading using opposite Y MAbs and Agios Pharm positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Y MAbs position performs unexpectedly, Agios Pharm can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agios Pharm will offset losses from the drop in Agios Pharm's long position.| Y MAbs vs. Revolution Medicines | Y MAbs vs. Black Diamond Therapeutics | Y MAbs vs. Passage Bio | Y MAbs vs. Bluebird bio |
| Agios Pharm vs. Mereo BioPharma Group | Agios Pharm vs. Blueprint Medicines Corp | Agios Pharm vs. Day One Biopharmaceuticals | Agios Pharm vs. Biomarin Pharmaceutical |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |